SCHEMBL23555264

SCHEMBL23555264

CN1CCC12CCCN(C(C)(C)C)C2

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.34
SOS2 Q07890 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12268288 0.92 SOS1 (0.34) SOS1SOS2
SCHEMBL20148741 0.86 SOS1 (0.37) SOS1SOS2
SCHEMBL22024162 0.86 SOS1 (0.35) SOS1SOS2
SCHEMBL23182189 0.86 SOS1 (0.39) SOS1SOS2
SCHEMBL17886522 0.83 SOS1 (0.36) SOS1SOS2
SCHEMBL19498050 0.83 CRHBP (0.38) SOS1SOS2
SCHEMBL24581323 0.81 CRHBP (0.32)
SCHEMBL20148742 0.76 GRIN2D (0.41)
SCHEMBL12563430 0.76 GRIN2D (0.41) SOS1SOS2
SCHEMBL1753460 0.74 SOS1 (0.39) SOS1SOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210186959-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA, INC. 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210186959-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF SOS1 566/4885SOS2 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.